𝛼SK or Search

ENTITY

Astellas Pharma (4503 JP)

228

Analysis

Health Care • Japan

Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia

more

Refresh

Exchange Announcement • 05 Aug 2026 14:30

Financial Results (Q1 Ytd/Fy2026)

Exchange Announcement • 05 Aug 2026 14:30

Supplementary Documents (Q1 Ytd/Fy2026)

Exchange Announcement • 05 Aug 2026 14:30

Presentation Material For Information Meeting (Q1 Ytd/Fy2026)

Exchange Announcement • 29 May 2026 15:00

Notice Regarding The Resignation Of An Outside Director And Partial Withdrawal Of Matters To Be Resolved At The 21st Term Annual Shareholders Meeting

Exchange Announcement • 26 May 2026 14:30

Astellas Announces Five-Year Corporate Strategic Plan To Deliver Greater Value Faster For Patients And Position Itself As A Sustainable Growth Company

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x